Anti-VEGF treatment also triggers oxygen and nutrient exhaustion through inhibition of angiogenesis and converts a glucose-dependent metabolism to a lipid-dependent metabolism, which ensures tumor growth even in the presence of few vessels 35 and cancer lipid metabolism has been proposed to confer antiangiogenic drug resistance. This evidence concerns the gene VEGFA and cancer.